Selvita to debut on main market this year

NewConnect-listed biotechnology firm Selvita would like to move to the main market of the Warsaw Stock Exchange before the end of this year, the company’s deputy CEO Bogusław Sieczkowski told ISBnews. “Final decisions about the potential share issue and its size will be made in the next few days. We are still considering several scenarios,” Sieczkowski said. Edison Investment Research value Selvita at PLN 210 million, or PLN 20 per share, according to a recent report. The company’s present capitalization on NewConnect is PLN 113 million or PLN 10.80 per share.